Invitae Q3 2016 Earnings Call - Genetic Testing

Invitae Corporation's Q3 2016 earnings call presentation covering financial results and operational highlights. The company reported ~200% year-over-year growth in billable reports, expanded to over 1,000 genes in production, and achieved an annual billing run rate of ~$70M while reducing cost of goods sold.